RU93004907A - Производные гидроксамовой кислоты и n-гидроксимочевины. способ их получения фармацевтическая композиция и способ лечения - Google Patents
Производные гидроксамовой кислоты и n-гидроксимочевины. способ их получения фармацевтическая композиция и способ леченияInfo
- Publication number
- RU93004907A RU93004907A RU93004907/04A RU93004907A RU93004907A RU 93004907 A RU93004907 A RU 93004907A RU 93004907/04 A RU93004907/04 A RU 93004907/04A RU 93004907 A RU93004907 A RU 93004907A RU 93004907 A RU93004907 A RU 93004907A
- Authority
- RU
- Russia
- Prior art keywords
- acid derivatives
- hydroxamic acid
- hydroxyurea
- producing
- treatment
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- VSNHCAURESNICA-UHFFFAOYSA-N hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 206010027654 Allergic conditions Diseases 0.000 claims 1
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 1
- 102000003820 Lipoxygenases Human genes 0.000 claims 1
- 108090000128 Lipoxygenases Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000002730 additional Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Claims (1)
- Новые производные гидроксамовой кислоты, имеющие структуру
ингибируют фермент липоксигеназу. Эти соединения и их фармацевтически приемлемые соли полезны при лечении или ослаблении воспалительных заболеваний, аллергических состояний и сердечно-сосудистых заболеваний у млекопитающих и в качестве активного компонента в фармацевтических композициях для лечения таких состояний.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2323814A JP3007138B2 (ja) | 1990-11-27 | 1990-11-27 | 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物 |
JP323814/90 | 1990-11-27 | ||
PCT/US1991/008246 WO1992009566A1 (en) | 1990-11-27 | 1991-11-13 | Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93004907A true RU93004907A (ru) | 1996-12-20 |
RU2104267C1 RU2104267C1 (ru) | 1998-02-10 |
Family
ID=18158900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93004907/04A RU2104267C1 (ru) | 1990-11-27 | 1991-11-13 | Способ получения n-гидроксимочевины, производные n-гидроксимочевины и способ ингибирования липоксигеназы у млекопитающих |
Country Status (32)
Country | Link |
---|---|
US (1) | US6291520B1 (ru) |
EP (1) | EP0559743B1 (ru) |
JP (1) | JP3007138B2 (ru) |
KR (1) | KR100192722B1 (ru) |
CN (1) | CN1029230C (ru) |
AT (1) | ATE119520T1 (ru) |
AU (1) | AU653763B2 (ru) |
BR (1) | BR9107124A (ru) |
CA (1) | CA2094137C (ru) |
CZ (1) | CZ281345B6 (ru) |
DE (2) | DE9190171U1 (ru) |
DK (1) | DK0559743T3 (ru) |
EG (1) | EG20001A (ru) |
ES (1) | ES2069410T3 (ru) |
FI (1) | FI932390A0 (ru) |
GR (1) | GR3015879T3 (ru) |
HU (1) | HU221975B1 (ru) |
IE (1) | IE64963B1 (ru) |
IL (1) | IL100100A (ru) |
MX (1) | MX9102209A (ru) |
MY (1) | MY107341A (ru) |
NO (1) | NO179582C (ru) |
NZ (1) | NZ240737A (ru) |
PL (1) | PL167584B1 (ru) |
PT (1) | PT99597B (ru) |
RU (1) | RU2104267C1 (ru) |
SK (1) | SK282645B6 (ru) |
TW (1) | TW262461B (ru) |
UA (1) | UA39166C2 (ru) |
WO (1) | WO1992009566A1 (ru) |
YU (1) | YU48416B (ru) |
ZA (1) | ZA919317B (ru) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE910980A1 (en) * | 1990-03-27 | 1991-10-09 | Smithkline Beecham Corp | 5-lipoxygenase inhibitors |
US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
JPH05294921A (ja) * | 1992-04-17 | 1993-11-09 | Pfizer Pharmaceut Co Ltd | 新規なフェニル置換シクロアルキル尿素誘導体および組成物 |
US5326787A (en) * | 1992-05-12 | 1994-07-05 | Abbott Laboratories | Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity |
US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
ES2152952T3 (es) * | 1992-07-13 | 2001-02-16 | Millennium Pharm Inc | 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes. |
US5648486A (en) * | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
WO1994018158A1 (en) * | 1993-02-15 | 1994-08-18 | Pfizer Inc. | Spiroalkylhydroxyureas for use as lipoxygenase inhibitors |
DK0693054T3 (da) * | 1993-04-07 | 1998-10-19 | Pfizer | Cycloalkylhydroxyurinstoffer og deres anvendelse som lipoxygenaseinhibitorer |
DE69421183T2 (de) * | 1993-07-20 | 2000-01-20 | Pfizer | Heteroaryl-cyloalkenyl-hydroxy-harnstoeffe |
TW448144B (en) * | 1993-08-19 | 2001-08-01 | Pfizer | Phenoxyphenyl cyclopentenyl hydroxyureas |
WO1995017379A1 (en) * | 1993-12-22 | 1995-06-29 | Pfizer Inc. | Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors |
US5750565A (en) | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5798383A (en) * | 1994-11-10 | 1998-08-25 | Pfizer Inc. | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas |
CN1059669C (zh) * | 1994-11-10 | 2000-12-20 | 辉瑞大药厂 | 芳氧基环烯基-和芳氧基亚氨基环烯基羟基脲类化合物 |
WO1996016054A1 (en) * | 1994-11-18 | 1996-05-30 | Pfizer Pharmaceuticals Inc. | Cycloalkenyl-n-hydroxyureas |
CA2210905A1 (en) * | 1995-02-02 | 1996-08-08 | Nikken Chemicals Co., Ltd. | N-hydroxyurea derivatives |
CA2176854A1 (en) * | 1995-06-07 | 1996-12-08 | Daniel J. Keavy | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
US6828460B2 (en) | 1999-03-22 | 2004-12-07 | Pfizer Inc. | Resorcinol derivatives |
EP1418173A1 (en) * | 1999-03-26 | 2004-05-12 | Ucb, S.A. | N-(3-butyn-1-yl) N-hydroxyurea |
US6521619B2 (en) | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
US20040029893A1 (en) * | 2002-07-23 | 2004-02-12 | Lane Edward M. | Method of treatment of non-invasive mucositis |
US20050043251A1 (en) * | 2003-08-20 | 2005-02-24 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20070078116A1 (en) * | 2003-08-20 | 2007-04-05 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20050159369A1 (en) * | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
KR100786479B1 (ko) | 2006-09-22 | 2007-12-17 | 삼성에스디아이 주식회사 | 평판표시장치 및 이를 이용한 휴대용 표시기기 |
BRPI0811639A2 (pt) | 2007-05-31 | 2014-09-30 | Sepracor Inc | Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina |
IN2012DN02698A (ru) | 2009-10-16 | 2015-09-04 | Syngenta Participations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3686733T2 (de) | 1985-03-16 | 1993-02-11 | Wellcome Found | Aryl-derivate. |
ES2053609T3 (es) | 1987-04-24 | 1994-08-01 | Abbott Lab | Derivados de urea inhibidores de lipoxigenasa. |
GB8830427D0 (en) * | 1988-12-30 | 1989-03-01 | Fujisawa Pharmaceutical Co | New hydroxylamine derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same |
US5120752A (en) | 1989-12-28 | 1992-06-09 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
GB9025514D0 (en) | 1990-11-23 | 1991-01-09 | Wellcome Found | Anti-inflammatory compounds |
DE4124345A1 (de) * | 1991-07-23 | 1993-01-28 | Gruenenthal Gmbh | Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
US5187192A (en) | 1992-03-13 | 1993-02-16 | Abbott Laboratories | Cyclobutyl derivatives having lipoxygenase inhibitory activity |
-
1990
- 1990-11-27 JP JP2323814A patent/JP3007138B2/ja not_active Expired - Fee Related
-
1991
- 1991-11-13 CZ CZ93990A patent/CZ281345B6/cs not_active IP Right Cessation
- 1991-11-13 RU RU93004907/04A patent/RU2104267C1/ru not_active IP Right Cessation
- 1991-11-13 DE DE9190171U patent/DE9190171U1/de not_active Expired - Lifetime
- 1991-11-13 ES ES92900454T patent/ES2069410T3/es not_active Expired - Lifetime
- 1991-11-13 CA CA002094137A patent/CA2094137C/en not_active Expired - Fee Related
- 1991-11-13 DE DE69108048T patent/DE69108048T2/de not_active Expired - Fee Related
- 1991-11-13 PL PL91299354A patent/PL167584B1/pl unknown
- 1991-11-13 UA UA93004013A patent/UA39166C2/ru unknown
- 1991-11-13 WO PCT/US1991/008246 patent/WO1992009566A1/en active IP Right Grant
- 1991-11-13 IE IE410191A patent/IE64963B1/en not_active IP Right Cessation
- 1991-11-13 BR BR919107124A patent/BR9107124A/pt not_active Application Discontinuation
- 1991-11-13 SK SK547-93A patent/SK282645B6/sk unknown
- 1991-11-13 DK DK92900454.7T patent/DK0559743T3/da active
- 1991-11-13 EP EP92900454A patent/EP0559743B1/en not_active Expired - Lifetime
- 1991-11-13 AU AU90535/91A patent/AU653763B2/en not_active Ceased
- 1991-11-13 US US08/070,327 patent/US6291520B1/en not_active Expired - Fee Related
- 1991-11-13 KR KR1019930701573A patent/KR100192722B1/ko not_active IP Right Cessation
- 1991-11-13 HU HU9301550A patent/HU221975B1/hu not_active IP Right Cessation
- 1991-11-13 AT AT92900454T patent/ATE119520T1/de not_active IP Right Cessation
- 1991-11-20 IL IL100100A patent/IL100100A/en active IP Right Grant
- 1991-11-22 MY MYPI91002169A patent/MY107341A/en unknown
- 1991-11-25 PT PT99597A patent/PT99597B/pt not_active IP Right Cessation
- 1991-11-25 EG EG71991A patent/EG20001A/xx active
- 1991-11-25 MX MX9102209A patent/MX9102209A/es not_active IP Right Cessation
- 1991-11-26 ZA ZA919317A patent/ZA919317B/xx unknown
- 1991-11-26 NZ NZ24073791A patent/NZ240737A/en unknown
- 1991-11-26 YU YU186291A patent/YU48416B/sh unknown
- 1991-11-26 CN CN91111219A patent/CN1029230C/zh not_active Expired - Fee Related
- 1991-12-05 TW TW080109550A patent/TW262461B/zh active
-
1993
- 1993-05-26 NO NO931921A patent/NO179582C/no not_active IP Right Cessation
- 1993-05-26 FI FI932390A patent/FI932390A0/fi unknown
-
1995
- 1995-04-19 GR GR950401015T patent/GR3015879T3/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93004907A (ru) | Производные гидроксамовой кислоты и n-гидроксимочевины. способ их получения фармацевтическая композиция и способ лечения | |
MY107341A (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
SE7903186L (sv) | Cerebralverksamt medel | |
RU93058555A (ru) | Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения или профилактики | |
RU92016453A (ru) | Гидроксамовые кислоты и n-гидроксимочевины, способы их получения, фармацевтическая композиция и способ ингибирования липоксигеназы | |
DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
NO180482C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive hydroksamsyrer og N-hydroksyurinstoffer | |
RU93053905A (ru) | Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
BG93298A (bg) | Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни | |
FI974444A0 (fi) | N-hydroksiureayhdisteitä anti-inflammatorisina aineina | |
RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
EA199700302A1 (ru) | Биологически активные уреидо-производные, полезные при лечении рассеянного склероза | |
RU93047670A (ru) | Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе | |
RU92016559A (ru) | Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения | |
RU94019332A (ru) | 2-замещенные пергидро-1-h-пиридо/1,2-а/пиразины, способ их получения, фармацевтическая композиция и способ лечения | |
RU94015603A (ru) | Производные 3-гидроксиантраниловой кислоты, способ их получения, фармацевтическая композиция, способ лечения и промежуточные соединения |